menu
    • menu

    Company profile for Eugia Pharma

    NEW Drugs in Dev: 9
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Envisioning a State of Global Well-Being. Eugia Pharma's aim is to deliver good-health globally, expeditiously. Our therapies extend to unmet medical needs in specialized products such as General Injectables, Oncology, Ophthalamics and Hormonal products. We at eugia believe that medical treatment should be patient-centric and value-oriented. To achieve this we have established 3 fundamental pillars at Eugia: superior patient e...
    Envisioning a State of Global Well-Being. Eugia Pharma's aim is to deliver good-health globally, expeditiously. Our therapies extend to unmet medical needs in specialized products such as General Injectables, Oncology, Ophthalamics and Hormonal products. We at eugia believe that medical treatment should be patient-centric and value-oriented. To achieve this we have established 3 fundamental pillars at Eugia: superior patient experience, quality and value-based care.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Eugia Pharmaindia-flag Flag
    Country
    Country
    India
    Address
    Address
    Forming part of Sy No 83/1, Hyderabad Knowledge City TSIIC Raidurg, Panmaktha ...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.eugiapharma.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/eugia-pharma-specialities-ltd
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BePharma

    Not Confirmed

    envelop Contact Supplier

    BePharma

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Eugia Pharma Receives USFDA Approval For Everolimus Tablets
    Eugia Pharma Receives USFDA Approval For Everolimus Tablets

    26 Feb 2026

    // INDPHARMAPOST

    https://www.indianpharmapost.com/drug-approval/eugia-pharma-receives-usfda-approval-for-everolimus-tablets-19224

    INDPHARMAPOST
    26 Feb 2026
    Share Share
    Eugia Pharma’s Generics Everolimus Receives Approval in US
    Eugia Pharma’s Generics Everolimus Receives Approval in US

    25 Feb 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219533

    FDA
    25 Feb 2026
    Share Share
    FDA Issues Form 483 to Eugia Pharma Specialities Limited
    FDA Issues Form 483 to Eugia Pharma Specialities Limited

    20 Feb 2026

    // FDA

    https://www.fda.gov/media/191109/download

    FDA
    20 Feb 2026
    Share Share
    Eugia’ Generics Nintedanib Receives Tentative Approval in US
    Eugia’ Generics Nintedanib Receives Tentative Approval in US

    04 Feb 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215123

    FDA
    04 Feb 2026
    Share Share
    Eugia Pharma’s Generics Mesna Receives Approval in US
    Eugia Pharma’s Generics Mesna Receives Approval in US

    27 Jan 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220518

    FDA
    27 Jan 2026
    Share Share
    Aurobindo Pharma Receives 9 Observations From USFDA For Eugia
    Aurobindo Pharma Receives 9 Observations From USFDA For Eugia

    15 Nov 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/aurobindo-pharma-gets-9-observations-from-usfda-for-unit-2-of-eugia-pharma-specialities-18247

    INDPHARMAPOST
    15 Nov 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search